Texas Capital Bancshares Inc Amgen Inc Transaction History

Texas Capital Bancshares Inc

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $1,344 - $1,622	5 Added 0.56%	893 $253,000
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $511 - $576	-2 Reduced 0.22%	888 $255,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $194,598 - $241,599	890 New	890 $239,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $4,290 - $5,228	19 Added 2.16%	899 $217,000
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $201,546 - $256,088	880 New	880 $231,000
Q2 2022 Aug 04, 2022	SELL	$230.71 - $256.74 $2,999 - $3,337	-13 Reduced 1.44%	889 $216,000
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $116,432 - $128,804	-531 Reduced 37.06%	902 $218,000
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $462,793 - $529,625	-2,327 Reduced 61.89%	1,433 $322,000
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $233 - $259	1 Added 0.03%	3,760 $916,000
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $516,384 - $601,762	2,327 Added 162.5%	3,759 $935,000
Q2 2020 Aug 03, 2020	SELL	$197.81 - $242.74 $2,373 - $2,912	-12 Reduced 0.83%	1,432 $338,000
Q4 2019 Jan 30, 2020	SELL	$189.21 - $243.2 $6,243 - $8,025	-33 Reduced 2.23%	1,444 $348,000
Q4 2018 Jan 29, 2019	SELL	$178.4 - $208.25 $18,553 - $21,658	-104 Reduced 6.58%	1,477 $288,000
Q1 2018 Apr 25, 2018	BUY	$169.43 - $198.0 $1,524 - $1,782	9 Added 0.57%	1,581 $270,000
Q4 2017 Jan 26, 2018	SELL	$168.79 - $188.59 $5,738 - $6,412	-34 Reduced 2.12%	1,572 $273,000
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $268,667 - $306,746	1,606	1,606 $299,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Texas Capital Bancshares Inc, based on Form 13F filings with the SEC.

Stay updated on Texas Capital Bancshares Inc with notifications on news.